Reva Medical launches Fantom in Switzerland with first implant of bioresorbable scaffold
Reva Medical (ASX:RVA) has expanded its commercial operations into Switzerland, the company said today, with the first implant of its Fantom bioresorbable scaffold.
The scaffold is made from Reva’s tyrosine-derived, radiopaque polymer, rendering Fantom visible under fluoroscopy – a characteristic that is unique to Reva’s product.
Get the full story at our sister site, Drug Delivery Business News.
The post Reva Medical launches Fantom in Switzerland with first implant of bioresorbable scaffold appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Pharmaceuticals Vascular Wall Street Beat Reva Medical Inc. Source Type: news
More News: Switzerland Health